2006;130(5):1390-1396. 203. Fihn SD, McDonell M, Martin D, et al. Risk factors for complications of chronic anticoagulation. A multicenter study. Warfarin Optimized Outpatient Follow-up Study Group. Ann Intern Med. 1993;118(7):511-520. 204. Nieto JA, Solano R, Ruiz-Ribo MD, et al. Fatal bleeding in patients receiving anticoagulant therapy for venous thromboembolism: ndings from the RIETE registry. J Thromb Haemost. 2010;8(6): 1216-1222. 205. Hutten BA, Prins MH, Gent M, Ginsberg J, Tijssen JG, Buller HR. Incidence of recurrent thromboembolic and bleeding complications among patients with venous thromboembolism in relation to both malignancy and achieved international normalized ratio: a retrospective analysis. Journal of clinical oncology: of cial journal of the American Society of Clinical Oncology. 2000;18(17):3078-3083. 206. Jun M, James MT, Manns BJ, et al. The association between kidney function and major bleeding in older adults with atrial brillation starting warfarin treatment: population based observational study. BMJ. 2015;350:h246. 207. Hylek EM, Singer DE. Risk factors for intracranial hemorrhage in outpatients taking warfarin. Ann Intern Med. 1994;120(11): 897-902. 208. Dentali F, Ageno W, Becattini C, et al. Prevalence and clinical history of incidental, asymptomatic pulmonary embolism: a meta- analysis. Thromb Res. 2010;125(6):518-522. 209. Hull RD, Raskob GE, Rosenbloom D, et al. Heparin for 5 days as compared with 10 days in the initial treatment of proximal venous thrombosis. N Engl J Med. 1990;322(18):1260-1264. 210. Lamberts M, Lip GY, Hansen ML, et al. Relation of nonsteroidal anti-in ammatory drugs to serious bleeding and thromboembolism risk in patients with atrial brillation receiving antithrombotic therapy: a nationwide cohort study. Ann Intern Med. 2014;161(10): 690-698. 211. Castellucci LA, Le Gal G, Rodger MA, Carrier M. Major bleeding during secondary prevention of venous thromboembolism in patients who have completed anticoagulation: a systematic review and meta-analysis. J Thromb Haemost. 2014;12(3):344-348. 212. 